Video

Ocular Allergy

Leonard Bielory, MD, reviews challenging cases of ocular allergy and discusses treatment options.

Leonard Bielory, MD, professor, Rutgers University and Robert Wood Johnson University Hospital in New Brunswick, New Jersey, reviews challenging cases of ocular allergy and discusses treatment options.

Related Videos
Image credit: Dr_Microbe | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit: Peter Hansen | stock.adobe.com
Related Content
Atlanta, GA, USA - June 15, 2022: Closeup of the CDC logo seen at the Edward R. Roybal campus, the headquarters of the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.
June 2nd 2025

CDC Clarifies That Kids May Receive COVID-19 Vaccine Through Shared Clinical Decision-Making

Luke Halpern, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
FDA Approves mRNA-1283 COVID-19 Vaccine for Adults 65 and Older, Those With Underlying Conditions
June 2nd 2025

FDA Approves mRNA-1283 COVID-19 Vaccine for Adults 65 and Older, Those With Underlying Conditions

Luke Halpern, Assistant Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
an anonymous adult man injecting himself a treatment such as insulin or Adalimumab, Etanercept or epinephrine into his shoulder. It is a white pen injector with red head for health care - Image credit: LaMorenita | stock.adobe.com
June 2nd 2025

FDA Grants Interchangeability Designation to Hadlima, a Biosimilar for Humira

Kennedy Ferruggia, Assistant Editor
X-ray of tumor on a patient's breast -- Image credit: peterschreiber.media | stock.adobe.com
June 2nd 2025

ASCO 2025: Vepdegestrant's Efficacy and Safety in ER+/HER2- Advanced Breast Cancer

Gillian McGovern, Associate Editor Erika Hamilton, MD